Investing News Show Replays – Small Cap Stocks To Buy

Best Small Cap Stocks To Buy

 Investing News Show Replays

Small Cap Stocks To Buy

 

June 30, 2015 Show

Skin Products Stocks

and

New Sunscreen Products Stocks on

Investment News Show

The show featured a live interview with

Terry Howlett, 

President & CEO of

Skinvisible, Inc.

Stock Symbol: SKVI

Listen To Show Replay Part 1:

Listen To Show Replay Part 2 With Terry Howlett, Skinvisible CEO Interview:

The Show also featured a live interview with Tim Connolly of Texas Gulf Oil & Gas Inc.  (See texasgulfoil.com site) and business funding and development specialists, Corporate Strategies, Inc. (See Site).

Listen To Show Replay Part 3 With Tim Connolly Oil Industry News Interview:

Corporate Strategies customizes a unique, immediate action plan to address each client’s specific needs. We assemble a team of seasoned professionals with extensive experience in your industry, who are experts in business development, finance, capital raising, operations, project management, due diligence and corporate restructuring services. The Corporate Strategies team is then ready to pursue the successful outcome as defined  by our client.

Texas Gulf Oil and Gas, Inc. (TGOG) is an independent oil and gas company based in Houston,Texas with field offices in Luling,Texas.

  • Our mission is to increase oil and gas production, using both conventional and proprietary enhanced production techniques, in previously proven production areas.
  • Due to the opportunity presented by dramatically lower oil prices, TGOG has begun to acquire and develop a three year target of 5,000+ barrels of oil equivalent (boepd) in shallow well production (approx 6000’ depth and less) per day in long standing production areas throughout Texas

skin products stocks

SKINVISIBLE PHARMACEUTICALS, INC.

See Skinvisible Corporate Site — Skinvisible.com Click Here

Get Skinvisible (SKVI) stock quote, trading chart and latest news from YAHOO finance — Click Here

Skin products stock news

Skinvisible, Inc., through its wholly owned subsidiary, Skinvisible Pharmaceuticals, Inc., is an R&D pharmaceutical company that develops enhanced, patent protected dermatology and healthcare products including products to treat acne, skin cancers, eczema, fungal infections, inflammation, warts and dermatitis along with sunscreens, anti-aging products, alcohol-free hand sanitizing lotions, pre-surgical preparations, and various other medical treatments using its patented technology Invisicare®. Skinvisible’s primary objective is to license these prescription and over-the-counter products into the $65 billion global dermatology market and other medical markets. Potential licensees include international and multi-national pharmaceutical, cosmetic, skincare and consumer goods companies seeking new products, product enhancements or life cycle management for their existing products.

Skin and Sunscreen Products Stocks 

Skinvisible’s mission is to develop innovative technology and superior topical polymer delivery vehicles designed to significantly enhance product performance for established brand manufacturers and marketers of Rx and OTC dermatological, medical, cosmetic and skincare products.

It is Skinvisible’s intention to direct its ongoing energies and resources towards the following objectives:

  • To capitalize on licensing opportunities for its Invisicare technology and formulated products to established pharmaceutical, medical, cosmetic, skincare and consumer goods manufacturers.
  • To develop new polymer delivery vehicles designed to create or enhance formulated products for existing and new customers for a variety of applications.
  • To enter into strategic relationships and attract alliances to expand research, development and collaborative product investigations for its patented polymer delivery vehicles and formulations.
  • To increase on-going revenues and profitability from current licensees.
  • To maximize shareholder value.

 Sunscreen Products Stocks

Terry Howlett — President & Chief Executive Officer

Mr. Howlett founded Skinvisible, Inc. in 1998. With over 30 years of entrepreneurial, business management and market initialization experience, he drives and directs the Company’s development and technology vision. He is adept at guiding emerging and publicly traded start-up companies through the stages of capital formation, strategic planning and business growth; specializing in venture capital financing. Mr. Howlett’s diversified background includes senior management, marketing, and sales positions with both established and start-up companies.

Sunscreen Products Stocks

Sunscreen Products Stock NEWS

SKINVISIBLE’S KINTARI REVOLUTIONIZES THE SUNSCREEN MARKET – Skinbrella® Officially Launched —  SEE NEWS

Skinvisible Inc., (OTCQB: SKVI) through its wholly-owned subsidiary Kintari International Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the official launch of Skinbrella®, a patented sunscreen like no other. Skinbrella meets or exceeds all FDA requirements for a broad-spectrum, 80 minute water-resistant sunscreen.

“With millions of new skin cancer diagnosis each year, sun protection should be a daily lifestyle choice for everyone,” said Mr. Terry Howlett, President of Kintari. “The challenge of course is many sunscreens breakdown when exposed to sunlight or esthetically they are not pleasing. Kintari provides a solution to everyone’s daily sunscreen needs with Skinbrella. Today we are thrilled to announce that Skinbrella; a truly remarkable sunscreen with the patents to prove it, is available on Kintari.com and through our independent distributors and their websites.”

Skinbrella is a broad spectrum, SPF 30 sunscreen made with the Company’s patented topical delivery technology Invisicare®. It provides 80 minutes of water resistance; the highest designation allowed by the FDA. Skinbrella glides on smoothly without any sticky after feel, while still allowing the skin to breath naturally. It meets the requirements to be labeled “broad spectrum”, signifying it provides both UVA and UVB protection.

sunscreen products stock news

SKINVISIBLE SUBSIDIARY KINTARI HAS SUCCESSFUL LAUNCH – Kintari Officially In Business — SEE NEWS

Skinvisible Inc., (OTCQB: SKVI) through its wholly owned subsidiary Kintari International Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the successful official launch of its network marketing company.

“We are very pleased to announce that our January 15th official launch of Kintari in the USA was very exciting for us and the new distributors that attended from across the US,” said Mr. Terry Howlett, President of Kintari.

The Kintari product portfolio consists of “Youth Renewed” (YR) anti-aging products to help fight the signs of aging. The Kintari YR product line includes a rejuvenating day cream and a renewing night cream. These products have been developed using proven anti-aging ingredients with scientific evidence of their effectiveness at reducing the look of fine lines and wrinkles resulting in youthful looking skin. These potent ingredients are powered by our patented Invisicare® skin delivery technology, providing consumers with unique, effective skincare benefits which cannot be duplicated and our Kintari distributors with products that no other company can offer. Kintari products are truly one of a kind.

skin products undervlaued stocksi

SKINVISIBLE’S SUBSIDIARY KINTARI ANNOUNCES NETWORK MARKETING EXPERT DEAN ALDRIDGE AS MASTER DISTRIBUTOR — SEE NEWS

Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) – through its wholly owned subsidiary Kintari International Inc., makers of patented “Youth Renewed” skin care products – is pleased to announce the selection of R. Dean Aldridge in the key role of Master Distributor. Dean will spearhead distributor expansion and development globally.

“We are very pleased to have Dean Aldridge, a world class marketer and sales leader, as our Master Distributor for Kintari,” said Terry Howlett, President of Kintari. “The Master Distributor plays a crucial role in the upward trajectory of the number of distributors that join Kintari and the sales they produce. Dean has exactly the skills and experience to make Kintari a huge success.” He added, “Dean has proven his skills over the past fifteen years in the network marketing industry. He is a multiple award winner and has climbed to the highest level of every company he has been associated with. Dean is often referred to as one of the top recruiters as well as one of the best relationship builders our industry has seen. His expertise has taken him to the top echelons of financial rewards and is touted as one of network marketing’s most distinguished international leaders.”

June 16, 2015 Show

June 16, 2015 Investment News Show featured a live interview with

Enzo Biochem Inc. (ENZ)

Director and President, BARRY W. WEINER 

Hear Part 1 of the show:

Watch Part 1 Video

small cap biotech stocks to buy

Hear Part 2 of the Show with Barry Weiner of Enzo Biochem Inc. interview:

Watch Part 2 Video

Undervalued biotech stocks

biotechnology stock to buy

Visit ENZO Corporate Site

Get ENZ stock quote, trading charts, and latest news – Click Here

undervalued biotechnology stock to buy

Enzo Biochem is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community.

biotech stock to buy

Founded in 1976, we have concentrated on the development of enabling technologies in the areas of gene regulation and gene modification. Many of our technologies are applicable to the biomedical and pharmaceutical research markets, and we are further using these technologies as a platform for our entry into the clinical diagnostics market.

biotech stock news

Today, Enzo technologies and products are recognized as the key tools in non-radioactive gene labeling used by researchers worldwide.

Additionally, Enzo’s work in gene analysis has led to development of a number of significant therapeutic candidates for the treatment of viral and immunological based disorders, several of which are in various phases of human clinical trials.

medical stock to buy

In the course of our extensive research and development activities, we have built a significant patent position consisting of numerous pioneer patents and applications that encompass our core technologies.

The business activities of Enzo Biochem are performed by the company’s three wholly owned subsidiaries:

Enzo Life Sciences, Enzo Therapeutics and Enzo Clinical Labs.

Such activities include research and development, manufacturing and marketing of biomedical research products and tools through Enzo Life Sciences and research and development of therapeutic products through Enzo Therapeutics and the operation of a regional clinical reference laboratory through Enzo Clinical Labs.

Enzo’s vision of the importance of recombinant DNA technology as an informational source more than two decades ago has now become a major direction in modern medicine.

See Enzo Stock News — Click Here

Enzo Biochem Reports Third Quarter Results, Including Strong Revenue Growth at Clinical Labs Reflecting Increasing Volume and Greater Molecular Diagnostic Activity — See More

BARRY W. WEINER, President, Chief Financial Officer, Principal Accounting Officer and Director and a founder of Enzo Biochem. He has served as the Company’s President since 1996, and previously held the position of Executive Vice President. Before his employment with Enzo Biochem, he worked in several managerial and marketing positions at the Colgate Palmolive Company. Mr. Weiner is a member of the New York Biotechnology Association. He received his Bachelor of Arts degree in Economics from New York University and a Master of Business Administration in Finance from Boston University.

Life Sciences and Biotechnology Stock

June 9, 2015 Show

June 9, 2015 Money Info Show

Investment News Show

The show featured a live interview with

Immune Therapeutics Inc.

(Stock Symbol: IMUN),

CEO Noreen Griffin

Dr G.B. ( Gloria ) Herndon

and Dr. Larry Grossman

Hear Part 1 of the show:

Hear Part 2 of the Show with Noreen Griffin Immune Therapeutics, Inc. CEO interview:

Get IMUN stock quote and latest news from Yahoo Finance – IMUN

Visit The Corporate Site — ImmuneTherapeutics.com

See Corporate Investors Information and stock quote page:
Click Here

 small cap medical stock

NEWS

Immune Therapeutics Inc. CEO Issues Letter to Shareholders Highlighting Significant Progress — See News

Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. — See News

Ms. Griffin, will be discussing the company’s accomplishments in dynamically effective approaches to combat a variety of chronic, life-threatening diseases.  Their novel concepts entail enhancing and refining both the activation and modulation of the body’s natural immune system.  The company’s therapies have been demonstrated over time to be highly efficacious and virtually free of side negative effects.

Immune Therapeutics is a specialty pharmaceutical company undergoing a wide range of FDA testing of therapeutic protocols preparatory to the manufacture, commercialization, marketing, and distribution of their patented therapies.

May 12, 2015 Show

The May 12 show featured a live interview with

Immune Therapeutics Inc.

(Stock Symbol: IMUN),

CEO Noreen Griffin

and

Dr. Gloria Herndon discussed her work with Immune Therapeutics, Inc. 

Listen to a replay of Part 1 of the show:

Listen to a replay of Part 2 of the show with Noreen Griffin of Immune Therapeutics, Inc. interview:

Undervalued Medical Stocks May 2015

Get IMUN stock quote and latest news – Click Here IMUN

Visit The Corporate Site — ImmuneTherapeutics.com

See Corporate Investors Information and stock quote page:
Click Here

small cap medical stock

Mrs. Herndon will discuss her work with Immune Therapeutics to combat a variety of chronic, life-threatening diseases.

See more on Mrs. Herndon and her work:

Unsung Heroine: Dr. Gloria Herndon — See The Huffington Post Article

Immune Therapeutics is a specialty pharmaceutical company undergoing a wide range of FDA testing of therapeutic protocols preparatory to the manufacture, commercialization, marketing, and distribution of their patented therapies.

Their novel concepts entail enhancing and refining both the activation and modulation of the body’s natural immune system.

The biotechnology company working to combat chronic, life-threatening diseases through the activation and modulation of the body’s immune system using our patented immunotherapy.

Their Products and immunotherapy technologies are designed to harness the power of the immune system to improve the treatment of cancer, infections such as HIV/AIDS, chronic inflammatory diseases, and autoimmune diseases.

The company’s therapies have been demonstrated over time to be highly efficacious and virtually free of side negative effects.

Small Cap Medical Stock News

Immune Therapeutics Inc, Announces the official publication announcement of the NAFDAC approved 90-Day Bridging Trial of Lodonal™ with HIV/AIDS Patients.

Immune Therapeutics Inc – Lodonal™ an Adjunct Immune Therapy for Treatment of Patients with HIV/AIDS

ORLANDO, Fla. and DUBLIN, May 4, 2015/PRNewswire/ — Immune Therapeutics Inc (IMUN) “Immune Therapeutics”, through its fully owned subsidiary, TNI Biotech International, today announced the dosing of the first patient with Lodonal™ (Once-daily OralTreatment) for the 90-Day bridging clinical trial of Immune Therapeutics’ proprietary patented therapy (Lodonal™) as an adjunct  treatment for HIV/AIDS and opportunistic infections. — See More

Immune Therapeutics Inc. CEO Issues Letter to Shareholders Highlighting Significant Progress — See News

Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. — See News

May 5, 2015 Show

Dr. Gloria Herndon will discuss her work with

Immune Therapeutics, Inc.

(Stock Symbol: IMUN)

Get IMUN stock quote and latest news from Yahoo Finance – IMUN

Visit The Corporate Site — ImmuneTherapeutics.com

See Corporate Investors Information and stock quote page:
Click Here

small cap medical stock

Mrs. Herndon will discuss her work with Immune Therapeutics to combat a variety of chronic, life-threatening diseases.

See more on Mrs. Herndon and her work:

Unsung Heroine: Dr. Gloria Herndon —See The Huffington Post Article

Immune Therapeutics is a specialty pharmaceutical company undergoing a wide range of FDA testing of therapeutic protocols preparatory to the manufacture, commercialization, marketing, and distribution of their patented therapies.

Their novel concepts entail enhancing and refining both the activation and modulation of the body’s natural immune system.

The company’s therapies have been demonstrated over time to be highly efficacious and virtually free of side negative effects.

Small Cap Medical Stock News

Immune Therapeutics Inc, Announces the official publication announcement of the NAFDAC approved 90-Day Bridging Trial of Lodonal™ with HIV/AIDS Patients.

Immune Therapeutics Inc – Lodonal™ an Adjunct Immune Therapy for Treatment of Patients with HIV/AIDS

ORLANDO, Fla. and DUBLIN, May 4, 2015 /PRNewswire/ — Immune Therapeutics Inc (IMUN) “Immune Therapeutics”, through its fully owned subsidiary, TNI Biotech International, today announced the dosing of the first patient with Lodonal™ (Once-daily OralTreatment) for the 90-Day bridging clinical trial of Immune Therapeutics’ proprietary patented therapy (Lodonal™) as an adjunct  treatment for HIV/AIDS and opportunistic infections. — See More

Immune Therapeutics Inc. CEO Issues Letter to Shareholders Highlighting Significant Progress — See News

Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. — See News

April 28, 2015 Show

The April 28, 2015 show featured a live interview with

RMS Medical Products, Inc.

(Stock Symbol: REPR)

President and Chairman of the Board of Directors Andrew Sealfon.

Small Cap Medical Stocks

RMS Medical Products, Inc.

(Stock Symbol: REPR)

Hear Part 1 of the show:

Hear Part 2 of the show with Andrew Sealfon Interview:

Visit the corporate website: http://www.rmsmedicalproducts.com

For REPR stock quotes, trading charts and their latest news releases visit this Yahoo Finance link: http://finance.yahoo.com/q?s=repr

Undervalued

Small Cap Medical Stocks

Visit the corporate website: http://www.rmsmedicalproducts.com

For REPR stock quotes, trading charts and their latest news releases visit this Yahoo Finance link: http://finance.yahoo.com/q?s=repr

Undervalued Small Cap Medical Stocks

REPR continues to increase revenues and create organic growth by using the cash from revenues to hire more staff, increase research efforts and expand marketing and sales.

STRONG GROWTH CONTINUES

REPR Annual Revenue and Profits Continue To Increase

New health insurance changes are forcing more and more home health care – A sector in which REPR excels.

RMS Medical Systems, Inc ( REPR 0.405 )* 

Has doubled this year already and can double again.

RMS designs, markets, manufactures portable easy to operate infusion devices, including needles and tubing. It is easy to handle by patients.

The Freedom 60 is being marketed in Europe as well as gaining a footing among home-care professionals in America. The RescueVac is used in ambulances and planes for emergency suction.

Medical Growth Stock

Sales for the FREEDOM 60® pump continue to produce spectacular grow.

RMS Medical Products specializes in developing and manufacturing portable medical devices,  understanding that healthcare professionals need products that they can depend on in critical situations – that will work every time. For patients, these products are often profoundly uplifting to their quality of life.

With that in mind, REPR offers products for a wide variety of markets including hospitals, home healthcare, nursing homes and rescue services.

Primary products are: 

FREEDOM60® Syringe Infusion System –  Used for the subcutaneous administration of immune globulin offers safe, controlled pressure and ability to adjust automatically to the flow. The inherently safe pressures used to deliver drugs to patients minimize discomfort, swelling and other complications sometimes found with conventional electric infusion devices. There are additional applications such as the delivery of antibiotics and other drugs. 

RES-Q-VAC® Emergency Suction – Fills a niche in emergency medicine, hospitals, and home care for immediate airway suction when and wherever needed. RES-Q-VAC® has patented filtration to minimize exposure of medical personnel to dangerous pathogens from patients infected with life threatening diseases such as tuberculosis and SARS. Because RES-Q-VAC® provides reliable suction without electric power, it is useful in disasters when the electricity fails.

RMS HIGH-Flo™  Subcutaneous Safety Needle Sets – RMS Successfully introduced this product to the US market during the 2012 fiscal year. Used with the Company’s FREEDOM60® pump or pumps from other manufacturers. The Company has received feedback from some SCIG patients experiencing less pain, less infusion time, and less discomfort when switching to High-Flo™.

 See more product information at

http://www.rmsmedicalproducts.com/?node=products

April 7, 2015 Show:

Money Info investment news show April 7, 2015 features stock market news, where to invest in April 2015 and small cap stocks to buy in the entertainment and oil sectors.

The show featured live executive interviews with

Energytek (Stock Symbol: ENTK )  future partner Terry Vickery, Managing Member of Energy Management Resources LLC

Visit Corporate site: EnergyTekCorp.com

Mr. Vickery discussed the recent EnergyTEK Corp. (ENTK) announcement that it has entered into a Letter of Intent with Energy Management Resources LLC (“EMR”) to form a joint venture to acquire the Working Interest of EMR, the lease operator, for up to 3 oil wells in Kentucky.

The acquisition would also include all existing equipment associated with the first well drilled by EMR.

Terry Vickery, Managing Member of EMR, commented,

“We are excited at the prospect of a joint venture with EnergyTEK in this promising oil production area, and look forward to completing our joint venture due diligence soon.”

Small Cap Oil Stock News

 EnergyTEK Corp. Enters Letter of Intent to Joint Venture 3 Well Oil Lease and Equipment in Kentucky — April 7, 2015 —  See News

The show also featured small cap entertainment stock CEO

Jake Shapiro of

Moon River Studios Symbol

Stock Symbol: FONU

Corporate Site: FONU2.com

Get stock quote at Yahoo Finance: FONU

Small Cap Entertainment Stock News

FONU2 Inc. Announces New Trailer for the Movie “Yellow” Directed by Nick Cassavetes — Apr 9, 2015 — See News

FONU2 Inc. (FONU) announced today that the Company has released a new trailer for the dark comedy, Yellow, written and directed by Nick Cassavetes. Edited by famed film editor Jim Flynn, the trailer showcases the “visual powerhouse” that Yellow is. The film stars Heather Wahlquist (Alphadog, the Notebook), Sienna Miller (American Sniper, Foxcatcher), Melanie Griffith(Working Girl, Bonfire of the Vanities), Ray Liotta (Goodfellas, Terminator 2), Gena Rowlands, Max Theriot and others.

 

FONU2 Inc. Announces New Website — Apr 8, 2015 — FONU2 (FONU) announced today that it has updated its website to reflect the strategic direction of the Company. As previously announced, among the assets acquired by FONU2 was the Intellectual Property rights to the name “Moon River Studios.” The Company has been operating its Studio Construction and film projects under this name.

See News

New owner steps up to buy Moon River Studios, the former Medient Studios in Effingham County — February 10, 2015

See News

Fonu2, Inc. (FONU) announced today it has acquired the 1,560 acre lease located in Effingham County, Georgia from Moon River Studios, Inc. (“Moon River”), located off Goshen Road in Rincon.

In addition to the lease, the Fonu2 has acquired certain intellectual property and trademarks associated with the project.

The property has an independently appraised value in excess of $22,000,000.

Indie Filmmakers Turning Heads on Wall Street — April 7, 2015 — 

See News

FONU2 Inc. is a film studio and production and social commerce company actively developing a 1,560 acre film studio complex in Effingham County, Georgia. Pre-construction and engineering have begun on the site with the initial warehouses and sound stages following. In addition to building the studio complex, the Company is in negotiations to purchase various film equipment packages. Both the facility space and the equipment will be used by the Company for its own productions and made available for rental to third parties.

The Company has also acquired the worldwide distribution rights to Nick Cassavetes’ Yellow, and will be producing a major motion picture to be directed by Penny Marshall. The Company’s social media division has invested in the development of a precision sales and marketing platform that integrates into the social media networks.

March 31, 2015 Show:

 Top Mining Stocks

on Investment News Show

The show features a live interview with

Phil Baker

CEO of Hecla Mining Company

Stock Symbol: NYSE Listed HL

Get stock quote and trading Chart:

Click here

See Corporate site:

Hecla-Mining.com

Hear a replay of Part 1 of the show:

Hear a replay of Part 2 of the show with

Hecla Mining Phil Baker interview:

Silver mining stocks to buy

Hecla Mining Company’s rich history of mining has distinguished it as a respected precious metals producer.

Hecla is not only the largest and one of the lowest-cost U.S. silver producers, but also a growing gold producer.

It is the oldest precious metals mining company in North America. 

Silver mining stocks to watch

MINING STOCK NEWS

Hecla Mining to Acquire Revett Mining for $20 Million

Hecla Mining Co. (NYSE:HL) and Revett Mining Company Inc. (TSX:RVM,NYSEMKT:RVM) announced that they have entered into a merger agreement under which Hecla will acquire Revett.

Each outstanding Revett share will be exchanged for 0.1622 of a common share of Hecla, which represents a 32-percent premium to Revett’s 20-day volume-weighted average price. The deal is reportedly worth $20 million.

Mining Stocks to buy

TOP MINING STOCK
Hecla Mining Company

Hecla Mining Company (NYSE:HL) is the largest primary silver producer in the U.S. and one of the lowest-cost producers, and a growing gold producer. The Company owns two primary silver mines in Alaska (Greens Creek) and Idaho (Lucky Friday) and the Casa Berardi gold mine in Quebec.  Expected 2015 silver production is 10.5 million ounces with expected gold production of 185,000 ounces.

In addition to its diversified silver and gold operating and cash-flow generating base, Hecla has a number of exploration properties and pre-development projects in five world-class silver and gold mining districts in North America. With an active exploration and development program, the company has consistently grown its reserve base for future production, with 2015 reserves totaling 173 million ounces of silver and 2.1 million ounces of gold reserves.

top Mining stocks to watch

Established in 1891, Hecla is headquartered in Coeur d’Alene, Idaho, and has a sister office in Vancouver, B.C. The company’s common stock has been traded on the New York Stock Exchange for 50 years.

Return to Investment News Show

MAIN PAGE – Click Here

 

Money Info Show

Replay Archives

Hear Replays of

March 2015 to

October 2014 Shows

Click Here

Hear Replays of

September 2014 to

July 2014 Shows

Click Here

Hear Replays of

July and June 2014 Shows

Click Here

Hear Replays of

May, April and

March 2014 Shows

Click Here

Hear Replays of

January and February 2014 Shows

Click Here

Hear Replays of

December and November 2013 Shows

Click Here

Hear Replays of October 2013 Shows

Click Here

Hear Replays of September 2013 Shows:

Click Here

Hear Replays of August 2013 Shows

Click Here

June 2013 and July 2013

Money Info Show Replays

Click Here

April 2013 and May 2013

Money Info Show Replays

Click Here

March 2013 and February 2013

Money Info Show Replays

Click Here

January 2013

Money Info Show Recaps

Click Here

November 2012

Money Info Show Replays

Get recaps of November Shows


October 2012

Money Info Show Replays

Get recaps of October Shows

September 2012

Money Info Show Replays

See past show recaps

Money Info

The Princeton Research Money Info Show features where to invest now, stock market, business, economy and financial investment news.

Money Info is hosted by Mike King and Charles Moskowitz

Stock Options Trading Alerts Update:

In order to make more investors aware of the exceptional gains we are producing with our Options Trading Alerts Service we are offering (for a very limited time) free sample trade alerts and sample issues of the Market Strategies Newsletter.

See http://www.princetonresearch.com/options-trading.htm to get in today.

Money Info

Money Info Investment News Show